Immunostaining in triple-negative breast cancer samples showed that higher adipocytic TAZ/Resistin expression associates with higher clinical stages and poorer survival, demonstrating promising therapeutic targets. The gene discussed is WWTR1; the disease is triple-negative breast carcinoma.